Neuropeptide Y concentrations in experimental Leishmania major cutaneous leishmaniasis

NeuroReport

Volumn 9, Issue 14, 1998, Pages 3271-3277

  Ahmed, Ahmed Abdelaziz ^a   Ahmed, Mahmood ^a   Theodorsson, Elvar ^b   Nordlind, Klas ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dorsal root ganglia; L. major; Lymph nodes; Mice; NPY; Skin; Spleen

Indexed keywords

NEUROPEPTIDE Y;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HORMONE DETERMINATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEISHMANIA MAJOR; LYMPHOID TISSUE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; SKIN; SKIN LEISHMANIASIS; SPINAL GANGLION; SPLEEN; TISSUE LEVEL;

EID: 0032487569     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199810050-00025     Document Type: Article

References (21)

1. Ridely DS. Pathology. In: Peters W and Killick Kendrick R, eds. The Laishmaniasis in Biology and Medicine. London: Academic Press, 1987: 665-695.
2. Kubba R, El-Hassan AM, Al-Gindan Y et al. Int J Dermatol 26, 527-531 (1987).
3. Satti MB, El-Hassan AM, Al-Gindan Y et al. Int J Dermatol 28, 243-247 (1989).
4. Wallengren J, Ekman R and Sundler F. Acta Derm Venereol (Stockh) 67, 185-192 (1987).
5. Tatemoto K, Carlquist M and Mutt V. Nature 296, 659-660 (1982).
6. Adrian TE, Allen JM, Bloom SR et al. Nature 206, 584-586 (1983).
7. Castagné V, Corder R, Gaillard R and Morméde P. Reg Pept 19, 55-63 (1987).
8. Irwin M, Brown M, Patterson T et al. FASEB J 5, 3100-3107 (1991).
9. De La Fuente MD, Bernaez I, Del Rio M and Hernanz A. Immunology 80, 259-265 (1993).
10. Ahmed AA, Wahbi A-H, Nordlind K et al. Scand J Immunol 48, 79-85 (1998).
11. Ericsson A, Larhammar D, McIntyre KR and Persson H. Immunol Rev 100, 261-277 (1987).
12. Schwarz H, Villiger PM, Kempis J and Lotz M. J Neuroimmunol 51, 53-61 (1994).
13. Kogner P, Ericsson A, Barbany G et al. Blood 80, 1324-1329 (1992).
14. Persson H, Ericsson A, Hemsén A et al. Expression of neuropeptide tyrosine (NPY) mRNA and peptide in non-neuronal cells. In: Mutt V, Hökfelt T, Fuxe K and Lundberg JM, eds. Neuropeptide Y. New York, Raven Press, 1988: 43-50.
15. Heinzel FP, Sadik MD, Holaday BJ et al. J Exp Med 169,59-72 (1989).
16. Nordlind K, Chen LB, Ahmed AA et al. Arch Dermatol Res 288,431-435 (1996).
17. Reichlin S. N Engl J Med 329, 1246-1253 (1993).
18. Felten SY, Felten DL, Bellinger DL and Olschowka JA. Noradrenergic and peptidergic innervation of lymphoid organs. In: Blalock JE, ed. Neuroimmunoendocrinology. Basel: Karger, 1992: 25-48.
19. Ru-Rong JI, Zhang X, Wiesenfeld-Hallin Z and Hökfelt T. J Neurosci 14, 6423-6434 (1994).
20. Chelmicka-Schorr E, Kwasniewski MN and Czlonkowska A. Int J Immunopharmacol 14, 841-846 (1992).
21. Theodos CM, Povinelli L, Molina R et al. Infect Immun 59, 2839-2842 (1991).